INTENSITY THERAPEUTICS, INC（INTS）美股招股说明书 S-1 （2022-01-07修订版）（英文版）（182页）.pdf

1、S-1/A 1 fs12021a5_intensity.htm REGISTRATION STATEMENTAs filed with the Securities and Exchange Commission on January 7,2022.Registration No.333-260565UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_Amendment No.5toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933_Int

2、ensity Therapeutics,Inc.(Exact name of registrant as specified in its charter)_Delaware283646-1488089(State or otherjurisdiction ofincorporation ororganization)(Primary standardindustrialclassification code number)(I.R.S.employeridentification number)_61 Wilton Road,3rd FloorWestport,CT06880Telephon

3、e:(203)221-7381(Address,includingzipcode,andtelephonenumber,includingareacode,ofregistrantsprincipale_Lewis H.BenderChief Executive Officer61 Wilton Road,3rd FloorWestport,CT06880Telephone:(203)221-7381(Name,address,including zip code,and telephone number,including area code,ofagent for service)_Cop

4、ies to:Robert H.Cohen,Esq.Daniel L.Woodard,Esq.McDermott Will&Emery LLPOne Vanderbilt AvenueNewYork,NY10017Telephone:(212)547-5400Ivan K.Blumenthal,Esq.Mintz,Levin,Cohn,Ferris,Glovskyand Popeo,P.C.666 Third AvenueNewYork,NewYork 10017Telephone:(212)935-3000_Approximate date of commencement of propos

5、ed sale to the public:Assoon as practicable after this registration statement becomes effective.If any of the securities being registered on this form are to be offered on adelayed or continuous basis pursuant to Rule415 under the Securities Actof1933,check the following box.If this form is filed to

6、 register additional securities for an offering pursuantto Rule 462(b)under the Securities Act,check the following box and list theSecurities Act registration statement number of the earlier effective registrationstatement for the same offering.If this form is a post-effective amendment filed pursua